MIND-NRG
Mind-NRG, based out of Switzerland, is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood - brain barrier through a receptor-mediated transport to reach its target in the brain. NRG-101 will be developed to treat disorders such as Parkinson's disease, Alzheimer's disease and schizophrenia. Mind-NRG will initially focus on conducting in vitro and in vivo experiments to further explore the mechanism of action of the peptide and to assess the activity of NRG-101 in a variety of relevant disease models.
MIND-NRG
Industry:
Biotechnology Medical Device Neuroscience
Founded:
2010-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.mind-nrg.com
Total Employee:
1+
Status:
Closed
Contact:
41 22 737 00 00
Email Addresses:
[email protected]
Total Funding:
23.7 M USD
Current Employees Featured
Founder
Investors List
Limburgse Reconversie Maatschappij
Limburgse Reconversie Maatschappij investment in Series B - Mind-NRG
Index Ventures
Index Ventures investment in Series B - Mind-NRG
Index Ventures
Index Ventures investment in Series A - Mind-NRG
Index Ventures
Index Ventures investment in Series A - Mind-NRG
More informations about "Mind-NRG"
Mind-NRG - Crunchbase Company Profile & Funding
Mind-NRG, based out of Switzerland, is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential …See details»
HOME - MindNrg Co-Creative Sanctuary
The separate training scholarships we provide ensure twice weekly access (except holidays and admin weeks between semesters) to a live, seasoned instructor for at least one year, so that all angles of this unique Biofeedback …See details»
Mind-NRG Company Profile 2024: Valuation, Investors ... - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Mind-NRG. Use the PitchBook Platform to explore the full profile.See details»
Mind-NRG - VentureRadar
Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the …See details»
Mindnrg Co-Creative Sanctuary - Facebook
Mindnrg Co-Creative Sanctuary. 733 likes. MindNRG is a brokerage company for QX World's latest generation of biofeedback devices, the Quex S and the Quex...See details»
MINDNRG™ CO-CREATIVE SANCTUARY
MindNrg Co-Creative Sanctuary is comprised of a network of dedicated professionals who have used, cultivated, and serviced the field of Quantum Biofeedback for over 15 years. MindNrg …See details»
Mind-NRG Sarl - Company Profile and News - Bloomberg Markets
Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases. The Company offers therapeutics that potentially modify diseases by crossing the blood-brain …See details»
Mind-NRG - Funding, Financials, Valuation & Investors - Crunchbase
Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases.See details»
Our Team - MindNrg Co-Creative Sanctuary
Working in the Biofeedback Industry since 2004, Jeremy has provided technical support and customer service to biofeedback practitoners and instructors for 20 years.See details»
Mind-NRG - Products, Competitors, Financials, Employees, …
Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the …See details»
Mind NRG Co-Creative Sanctuary - Facebook
Mind NRG Co-Creative Sanctuary. 506 likes. Greetings All! Welcome! We're glad you're here. This is a forum for quantum biofeedback practitioners seeking the best device placement services possible...See details»
Mind-NRG - Contacts, Employees, Board Members, Advisors
Mind-NRG has 1 current employee profile, FounderGage Tarrant. Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases.See details»
Index founds Mind-NRG with $13.8M investment | Fierce Biotech
Oct 27, 2010 · Index Ventures says that Switzerland-base Mind-NRG has opened its doors with a Series A financing of €10 million ($13.8 million). Mind-NRG is developing NRG-101, a peptidic …See details»
Mind-NRG - BioCentury Company Profiles - BCIQ
Mind-NRG - BioCentury Company Profiles for the biopharma industrySee details»
Mind-NRG Successfully Completes 6 Million Euro (~8 Million USD) …
Sep 4, 2013 · Geneva, Switzerland, September 4th 2013 – Mind-NRG, the Swiss-based company focusing on developing neuregulins to treat neurodegenerative diseases, announces the close …See details»
Specials - MindNrg Co-Creative Sanctuary
Welcome to our Specials page. The Products and Vendors we have selected to promote have been chosen based on relevance, reputation, and positive relationships with both MindNrg, as …See details»
Mind-NRG Closes EUR6M Funding Round - PitchBook
Mind-NRG, a Swiss-based company developing treatments for neurodegenerative diseases, has closed a €6 million ($7.9 million) Series B round of funding led by new investor LRM. …See details»
Mind-NRG | VentureRadar
Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the …See details»
ISS | MindNRG Co-Creative Sanctuary - Facebook
This is an educational and informational forum to discuss various applications of Biofeedback and other related modalities and wellness concerns. Our rules are simple: remain friendly, polite …See details»
Mind Sports Organisation - Wikipedia
The first Mind Sports Olympiad was held in London's Royal Festival Hall in 1997. It brought together an unprecedented number of strategy games and events. William Hartston in The …See details»